Scott Bizily, Chief Legal Officer at 4D Molecular Therapeutics, Inc. (FDMT), sold 3,500 shares at $31.27 ($109K) on 2024-03-18, disclosed to the SEC on 2024-03-20.
Scheduled sale ($109k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.27 | 1,750 | $55K | 50.0% |
| 2 | $31.27 | 1,750 | $55K | 50.0% |
| Total | $31.27 avg | 3,500 | $109K | 100% |
| Filing → |
| FDMT | SELL | 2026-08-17 | $40K | — | Filing → |
| FDMT | SELL | 2026-07-02 | $92K | — | Filing → |
| FDMT | SELL | 2026-06-25 | $118K | — | Filing → |